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Briana J. Taylor, MS 
 
University of Pittsburgh, 2014 
 
 
Circadian rhythms are critical to health and functioning. Circadian misalignment can result from 
desynchrony between sleep-wake cycles and the natural light-dark cycle, disrupting time-
dependent variations in biological functioning associated with metabolism and energy 
homeostasis. Here, we test a chronobiological model suggesting that sleep timing may act on 
health outcomes via a melatonergic-metabolic pathway by gating the effect of light on circadian 
signaling. We evaluated associations between four measures of sleep timing and indices of 
metabolic health in order to assess the importance of sleep timing for healthy functioning in 
midlife women.   
Participants were 338 Caucasian (n = 161), African American (n = 121) and Chinese (n = 
56) women who participated in the SWAN Sleep Study and who were not taking insulin or other 
insulin-related medications. Participants reported habitual sleep-wake times in the Pittsburgh 
Sleep Diary for a minimum of 11 nights. From self-reported sleep-wake times, four 
measurements of sleep timing were calculated: average bedtime, variability in bedtime, bedtime 
delay, and social jetlag. Body mass index (BMI) and the homeostasis model assessment of 
insulin resistance (HOMA-IR) were measured at two time points (average years between time 
points = 5.39 ± 0.71). We expected later average bedtime, greater variability in bedtime, more 
bedtime delay, and more social jetlag to be associated with higher BMI and higher HOMA-IR at 
time one and time two. 
Greater variability in bedtime was associated with higher HOMA-IR at Time 1 after 
controlling for race, menopausal status, sleep duration, exercise, depression, and BMI (β = .132; 
p = .005). Moreover, fully adjusted cross-sectional models also revealed significant positive 
associations between bedtime delay and both BMI (β = .128; p < .001) and HOMA-IR (β = .098; 
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p = .038). Average bedtime and social jetlag were unrelated to metabolic health in cross-
sectional analyses and no measure of sleep timing was associated with either measure of 
metabolic health in prospective analyses. 
These data indicate that individual differences in sleep timing are associated with 
metabolic health in a non-shift working population. The current findings provide support for a 
chronobiological model linking sleep timing with metabolic health.
 v 
 
TABLE OF CONTENTS 
 
 
 
 
1.0 INTRODUCTION ..................................................................................................................... 1 
1.1 SLEEP TIMING AND METABOLIC HEALTH ........................................................ 2 
1.1.1 Epidemiology of metabolic disturbances in shift workers ........................ 2 
1.1.2 Observational studies in non-shift workers............................................... 3 
1.1.3 Manipulations of sleep timing and metabolic functioning........................ 5 
1.2 CHRONOBIOLOGICAL MECHANISMS LINKING SLEEP TIMING AND METABOLIC 
HEALTH ...................................................................................................................... 6 
1.3 SLEEP TIMING AND METABOLIC HEALTH IN MIDLIFE WOMEN ................. 8 
1.4 THE PRESENT STUDY .............................................................................................. 9 
2.0 RESEARCH DESIGN AND METHODS ............................................................................... 10 
2.1 PARTICIPANTS AND PROTOCOL ........................................................................ 10 
2.2 SLEEP TIMING ......................................................................................................... 11 
2.3 BODY MASS INDEX ............................................................................................... 11 
2.4 INSULIN RESISTANCE ........................................................................................... 12 
2.5 SAMPLE CHARACTERISTICS AND CANDIDATE COVARIATES ................... 12 
2.6 STATISTICAL ANALYSIS ...................................................................................... 13 
2.6.1 DESCRIPTIVE STATISTICS AND COVARIATE EVALUATION ... 13 
2.6.2 CROSS-SECTIONAL ANALYSES ...................................................... 13 
2.6.3 PROSPECTIVE ANALYSES ................................................................ 13 
2.6.4 EXPLORATORY ANALYSES ............................................................. 14
 vi 
 
 
3.0 RESULTS ................................................................................................................................ 15 
3.1 SOCIO-DEMOGRAPHIC CORRELATES OF SLEEP TIMING ............................ 17 
3.2 HEALTH CORRELATES OF SLEEP TIMING ....................................................... 18 
3.3 SLEEP CORRELATES OF SLEEP TIMING ........................................................... 18 
3.4 COVARIATE SELECTION ...................................................................................... 18 
3.5 CROSS-SECTIONAL ASSOCIATIONS BETWEEN SLEEP TIMING AND BMI 19 
3.6 CROSS-SECTIONAL ASSOCIATIONS BETWEEN SLEEP TIMING AND HOMA-IR
 .................................................................................................................................... 19 
3.7 PROSPECTIVE ASSOCIATIONS BETWEEN SLEEP TIMING AND METABOLIC 
HEALTH .................................................................................................................... 20 
3.8 AD-HOC EXPLORATORY ANALYSES ................................................................ 20 
3.8.1 DO ASSOCIATIONS BETWEEN SLEEP TIMING AND METABOLIC 
HEALTH VARY BY STUDY SITE OR SEASON? ............................. 20 
3.8.2 DO ASSOCIATIONS BETWEEN SLEEP TIMING AND METABOLIC 
HEALTH VARY BY RACE? ................................................................ 21 
3.8.2.1 SENSITIVITY ANALYSIS ...................................................... 21 
4.0 DISCUSSION AND CONCLUSIONS ................................................................................... 22 
TABLES AND FIGURES ............................................................................................................. 30 
APPENDIX TABLES .................................................................................................................... 43 
BIBLIOGRAPHY .......................................................................................................................... 62
 vii 
 
LIST OF TABLES 
 
 
 
Table 1 Sample characteristics by race ..............................................................................30 
Table 2 Demographic, health and sleep characteristics across early, moderate and late bedtime 
categories ...........................................................................................................................31 
Table 3 Demographic, health and sleep characteristics across low, moderate and high bedtime 
variability categories ..........................................................................................................32 
Table 4 Demographic, health and sleep characteristics across low, moderate and high bedtime 
delay categories ..................................................................................................................33 
Table 5 Demographic, health and sleep characteristics across low, moderate and high social 
jetlag categories .................................................................................................................34 
Table 6 Summary of regression analyses examining cross-sectional associations between sleep-
timing variables and BMI ..................................................................................................35 
Table 7 Summary of regression analyses examining cross-sectional associations between sleep-
timing variables and HOMA-IR ........................................................................................36 
Table 8 Summary of regression analyses examining prospective associations between sleep-
timing variables and BMI ..................................................................................................37 
Table 9 Summary of regression analyses examining prospective associations between sleep-
timing variables and HOMA-IR ........................................................................................38 
Table 10 Sensitivity analysis examining cross-sectional associations between sleep-timing 
variables and HOMA-IR excluding Chinese women ........................................................39
 viii 
 
Table A1 Correlation matrix of sleep timing variables .....................................................43 
Table A2 Cross-sectional regression results predicting BMI with average bedtime .........44 
Table A3 Cross-sectional regression results predicting BMI with variability in bedtime .45 
Table A4 Cross-sectional regression results predicting BMI with bedtime delay .............46 
Table A5 Cross-sectional regression results predicting BMI with social jetlag ................47 
Table A6 Cross-sectional regression results predicting HOMA-IR with average bedtime ...
............................................................................................................................................48 
Table A7 Cross-sectional regression results predicting HOMA-IR with variability in bedtime
............................................................................................................................................49 
Table A8 Cross-sectional regression results predicting HOMA-IR with bedtime delay ...50 
Table A9 Cross-sectional regression results predicting HOMA-IR with social jetlag ......51 
Table A10 Prospective regression results predicting BMI with average bedtime .............52 
Table A11 Prospective regression results predicting BMI with variability in bedtime .....53 
Table A12 Prospective regression results predicting BMI with bedtime delay .................54 
Table A13 Prospective regression results predicting BMI with social jetlag ....................55 
Table A14 Prospective regression results predicting HOMA-IR with average bedtime ...56 
Table A15 Prospective regression results predicting HOMA-IR with variability in bedtime
............................................................................................................................................57 
Table A16 Prospective regression results predicting HOMA-IR with bedtime delay .......58 
Table A17 Prospective regression results predicting HOMA-IR with social jetlag ..........59  
Table A18 Body mass index and HOMA-IR Time 1 and Time 2 correlations .................60 
Table A19 Significant differences between participants included and excluded from primary 
analyses .......................  ......................................................................................................61 
 ix 
 
LIST OF FIGURES 
 
Figure 1 Nocturnal energy expenditure and light at night .................................................40 
Figure 2 Mean sleep timing values among Caucasian, African American and Chinese women
............................................................................................................................................41 
Figure 3 Interaction between race and variability in bedtime predicting HOMA-IR ........42 
 
 
 
 
 
1 
 
1.0 INTRODUCTION 
 
Mounting evidence suggests that sleep and circadian misalignment are important for metabolic 
health. The sleep and health literature has primarily focused on the metabolic consequences of 
sleep disorders such as obstructive sleep apnea and insomnia while a separate literature has 
documented the adverse metabolic health outcomes associated with shift work due to circadian 
dysregulation. This work has given rise to an interest in more moderate sleep disturbances and 
shifts in circadian rhythms. An emerging literature on social jetlag suggests that bedtime delay 
on free days, relative to work days, may be similarly associated with metabolic health problems 
such as obesity. However, far less is known about the day-to-day timing of sleep in relation to 
metabolic health. Accordingly, the proposed study seeks to assess indices of sleep timing, 
namely average bed time, variability in bedtime, social jetlag, and intra-week bedtime delay, in 
relation to metabolic health in midlife women. 
Sleep timing is an integral component of the two primary processes regulating sleep: 
homeostatic sleep drive and circadian rhythms. Under normal conditions, the need for sleep, or 
homeostatic sleep pressure, builds across the day and is counteracted by a circadian wake-
promoting system. These two systems work dynamically and in tandem to promote distinct and 
consolidated periods of sleep and wake (Gillette & Sejnowski, 2005). Changes in the timing of 
sleep can result in desynchrony between homeostatic sleep drive and circadian rhythms, leading 
to sleep disturbances, including sleep fragmentation, insufficient sleep duration, and changes in 
perceived sleep quality (Burgess & Eastman, 2004). A strong body of literature suggests that 
indices of sleep disturbance are associated with metabolic disturbances including obesity, insulin 
resistance and type II diabetes (Hall et al., 2012; Tasali, Leproult, Ehrmann, & Van Cauter, 
2008; Patterson et al., 2014; Ohkuma et al., 2013; Lucassen, Rother, & Cizza, 2012; Grandner, 
Jackson, Pak, & Gehrman, 2012; Choi et al., 2008; Kobayashi, Takahashi, Deshpande, Shimbo, 
& Fukui, 2011; Hall et al., 2008). However, sleep timing itself may have implications for 
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metabolic health independent of sleep disturbances by dysregulating circadian signaling, thereby 
creating desynchrony among physiological pacemakers.   
The associations between sleep timing and circadian rhythms have been most thoroughly 
explored through the epidemiological work in permanent and rotating shift workers. More 
recently, several studies have found that non-shift workers with late or irregular sleep times may 
also be at an increased risk for developing metabolic health problems (Logue, Scott, Palmieri, & 
Dudley, 2014a; Bailey et al., 2014a). Experimental chronobiology studies have supported these 
observational findings by identifying specific aspects of metabolic physiology that undergo acute 
changes in response to circadian dysregulation conditions (Buxton et al., 2012; Scheer, Hilton, 
Mantzoros, & Shea, 2009). Taken as a whole, the current literature provides compelling support 
for an evaluation of sleep timing as a more naturalistic index of circadian alignment which may 
be relevant for metabolic health and functioning. 
 
1.1 SLEEP TIMING AND METABOLIC HEALTH 
 
1.1.1 Epidemiology of metabolic health disturbance among shift workers 
 
Shift work is characterized by abnormal sleep/wake patterns. Permanent night shift workers are 
often 12 hours out of phase with the light/dark cycle while rotating shift workers experience 
abrupt shifts in their sleep/wake routines as frequently as every few days. Obesity is a common 
health problem for men and women in both types of shift work (Zimberg, Fernandes Junior, 
Crispim, Tufik, & de Mello, 2012; Wang, Armstrong, Cairns, Key, & Travis, 2011; Szosland, 
2010). A cross-sectional study of roughly 10,000 female nurses in Korea showed a linear trend 
between the prevalence of overweight/obesity and duration of shift work exposure (Kim, Lee, & 
Duffy, 2013). Moreover, rotating shift work was independently associated with significant 
increases in BMI relative to day-working matched controls in a 14 year, longitudinal study 
(Suwazono et al., 2008).  
The prevalence of insulin resistance and type II diabetes are also disproportionately high 
in shift workers. A longitudinal analysis showed that rotating shift work was associated with a 
1.35 odds ratio (OR) for new onset of diabetes in a sample of 3,203 day workers and 2,426 
rotating shift workers (Suwazono et al., 2006). The Nurse’s Health Study I and II (NHS I and 
NHS II) also found associations between shift work and type II diabetes in a large sample (N = 
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177,000) of young and midlife women (Pan, Schernhammer, Sun, & Hu, 2011). Pooled hazard 
ratios revealed a monotonic relationship between years of shift work exposure and risk for type 
II diabetes. Taken as a whole, the epidemiological literature in shift workers provides large-scale 
observational evidence to support the link between circadian misalignment and metabolic health 
disturbances. Though sleep timing is an inherent characteristic of circadian misalignment in shift 
workers, it is rarely evaluated for its independent contribution to health outcomes. 
 
1.1.2 Observational studies in non-shift workers 
 
Sleep timing is an understudied dimension of sleep in the general population as well. To our 
knowledge, only three studies have evaluated bedtime in relation to metabolic health in non-shift 
workers. A cross-sectional study of 2,200 Australian adolescents found that later bedtime was 
associated with increased BMI (Vanhelst, Bui-Xuan, Fardy, & Mikulovic, 2013; Golley, Maher, 
Matricciani, & Olds, 2013). In this sample, teens with a later bedtime were 1.5 times more likely 
to be obese compared to teens with an earlier bedtime after controlling for sleep duration and 
physical activity levels (Golley et al., 2013). Late bedtime has also been associated with 
overweight status among adults with intellectual disabilities after controlling for sleep duration 
(Mikulovic, Dieu, Fardy, Bui-Xuan, & Vanhelst, 2014). Finally, a cross-sectional study among 
adults with type II diabetes found that early bedtime was strongly associated with better 
glycemic control after adjusting for diet, physical activity, and other measures of sleep 
(Reutrakul et al., 2013).   
Even less is understood about variability in bedtime, due to very limited research and 
inconsistent findings. Data collected from an urban family medical center indicated that stable 
bedtimes were an important correlate of obesity in adult men and women (Logue, Scott, 
Palmieri, & Dudley, 2014b). Using the Sleep Timing Questionnaire (Monk & Buysse, 2003), 
Logue and colleagues (2014) showed that greater variability in bedtime during both the week and 
the weekend was associated with an increased risk for being obese (OR = 2.3; p = 008 and OR = 
1.8; p = .04, respectively). Another study measured sleep timing for seven days using actigraphy 
and sleep diaries in young, adult women (Bailey et al., 2014b). This study showed that greater 
variability in bedtime was associated with increased percentage of body fat (β = .13; p = .017) 
and BMI (β = .11; p = .041). In these studies, neither average bedtime nor sleep duration was 
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associated with health outcomes. These studies indicate that day-to-day variability in sleep 
timing may be an overlooked risk factor for metabolic health problems. However, a separate 
epidemiological study of men and women found that sleep timing was not consistently 
associated with obesity, but that variability in sleep duration predicted a 1.63 and 1.22 fold 
increase in the risk for being obese in men and women, respectively (Patel et al., 2014). 
Longitudinal assessments are needed in order to understand whether sleep timing may be 
causally related to the trajectory of metabolic health. As of yet, no prospective studies have 
assessed the relationship between indices of sleep timing and changes in metabolic health over 
time. 
Social jetlag is an additional index of sleep timing that has recently entered the public 
health arena (Roenneberg, Allebrandt, Merrow, & Vetter, 2012; Touitou, 2013; Garaulet et al., 
2013). Social jetlag is the discrepancy between sleep time on free days and sleep time on 
work/school days, which can be similar to shifts in sleep and circadian rhythms associated with 
cross-meridian travel (i.e., “jetlag”). Social jetlag is thought to result from a discrepancy between 
endogenous circadian timing and social timing, which may not only result in sleep loss, but also 
desynchrony among internal pacemakers. This desynchrony may affect energy homeostasis 
through down-stream circadian signaling cascades. Based on data from a large European sample, 
Roenneberg and colleagues (2012) examined social jetlag in relation to BMI and found that 69% 
of the represented population reported at least one hour of social jetlag each week, which in turn, 
was predictive of being overweight (BMI ≥ 25). This finding was robust after adjusting for sleep 
duration. Only two subsequent studies have examined social jetlag in relation to metabolic 
health; however, these studies reported null associations between social jetlag and both BMI 
(Rutters et al., 2014) and homeostasis model assessment of insulin resistance (HOMA-IR; 
Kantermann, 2014). These studies were characterized by small sample sizes and heterogeneous 
samples, suggesting that more work is needed to understand whether weekly shifts in sleep 
timing may be a prominent risk factor for metabolic health, independent of factors such as 
average sleep duration.   
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1.1.3 Manipulations of sleep timing & metabolic functioning 
 
Mechanisms to explain the link between circadian desynchrony and metabolic health have been 
explored. Potential mechanisms have included metabolic dysregulation due to insufficient sleep, 
the influence of sleep deprivation on dietary preference, and reduced physical activity and 
availability of healthy foods during nighttime hours compared to daytime hours (Ekmekcioglu & 
Touitou, 2011).  Although it is clear that dietary behavior and a positive energy balance (i.e., 
more calories consumed than expended) contribute to weight gain within the context of circadian 
misalignment, the independent effects of sleep timing on metabolic health are less clear and are 
often confounded by changes in sleep duration. 
Buxton and colleagues (2012) systematically assessed the effect of circadian 
misalignment on metabolic physiology (Buxton et al., 2012). Participants in this study were 
placed on an imposed schedule of sleeping, waking, fasting and feeding that was delayed by four 
hours each day over three weeks. After one week, participants were sleeping during the day and 
awake at night. Allowed sleep time was also limited to 5.6 hours per 24 hours. By the end of five 
weeks, participants’ resting metabolic rate had reduced by 8% and pancreatic insulin secretion 
had dropped by approximatley 33%. This finding suggested that dramatic delays in both sleep 
and eating time contributed to metabolic dysfunction, potentially by decreasing energy 
expenditure and the body’s ability to metabolize glucose.    
Pancreatic insulin secretion may be particularly sensitive to changes in circadian rhythms, 
independent of sleep. Scheer and colleagues (2009) found that following a circadian 
misalignment protocol, participants demonstrated impaired pancreatic insulin production and 
higher glucose, independent of changes in sleep efficiency. Studies of sleep restriction in the 
absence of circadian misalignment have reported on reduced insulin sensitivity despite no 
changes in pancreatic insulin secretion (Buxton et al., 2010). These studies indicate that 
misaligned sleep-wake cycles may have detrimental effects on metabolic health, independent of 
sleep duration and efficiency, and that sleep timing may uniquely act on a chronobiological 
pathway specific to pancreatic insulin functioning.   
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1.2 CHRONOBIOLOGICAL MECHANISMS LINKING SLEEP TIMING AND 
METABOLIC HEALTH 
 
Sleep timing may influence circadian signals involved in the chronobiological regulation of 
metabolic functioning. Energy metabolism rhythms are synchronized by a hierarchical system of 
internal pacemakers including a “central clock” known as the suprachiasmatic nucleus (SCN), 
and “peripheral clocks” located in tissues throughout the body. The SCN is a small cluster of 
cells located near the hypothalamus which is reset daily by exposure to light (Gillette & 
Tischkau, 1999; Kennaway, 1998). The SCN receives non-visual information from light-dark 
cycles via specialized retinal ganglion cells and projects information about the environmental 
photoperiod to peripheral tissues via hormonal signaling cascades (Pevet & Challet, 2011; 
Maywood, O'Neill, Chesham, & Hastings, 2007). When light is perceived, the SCN signals the 
pineal gland to suppress melatonin production, inhibiting sleep and promoting wakefulness. 
Melatonin is one of the most robust circadian signals, referred to as the “arm” of the circadian 
clock. Moreover, melatonin appears to play a prominent role in regulating rhythms of energy 
storage and energy expenditure. 
Metabolic processes demonstrate distinct temporal organization, fluctuating between 
phases of energy storage (anabolic) and energy expenditure (catabolic). During the anabolic 
phase, carbohydrates are broken down into energy, or glucose. Glucose is converted into 
glycogen through a process called glycogenesis so that it can be stored in liver, adipose, and 
muscle tissues via insulin transport. During the catabolic phase, glycogen is converted back into 
glucose, through a process called glycogenolysis, to be circulated in the blood for use during 
periods of fasting such as sleep. The anabolic and catabolic phases of digestion rely on the 
temporal sequestration of glycogenesis and glycogenolysis to create rhythmic and distinct 
patterns of energy storage and energy expenditure, thereby achieving energy homeostasis. 
Glycogenesis and glycogenolysis are in synchrony with predictable rhythms of sleeping-waking, 
thought to reflect evolutionary behavior patterns of foraging for food during the day and fasting 
at night (Arble, Ramsey, Bass, & Turek, 2010).   
Melatonin facilitates the temporal sequestration of the anabolic and catabolic phases of 
metabolism in part by regulating pancreatic insulin production. When melatonin is produced, it 
binds with receptors on pancreatic islets to inhibit beta-cell production of insulin. As seen in 
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Figure 1, decreased levels of insulin at night are necessary to initiate the catabolic phase of 
metabolism, allowing stored energy to be released back into the blood stream to maintain basal 
cellular functioning during the anticipated fasting period (i.e. sleep). However, the absence of 
melatonin can result in disinhibited insulin secretion at night, prolonging the energy storage 
phase. This becomes problematic due to the limited capacity of glycogen stores which is 
typically reached by the end of the day (Danforth, 1965; Chen, Williams, Cooney, & Caterson, 
1992; Barclay, Eley, Buysse, Maughan, & Gregory, 2012). When glycogen stores are full and 
insulin is not inhibited by melatonin, glucose is directed into tissues that can no longer absorb it 
properly. Excess glucose either remains in circulation, contributing to a hyperglycemic state, or 
is transported into tissues and stored as fat (see Figure 1), both of which are risk factors for 
adverse metabolic health outcomes. Regular secretion of melatonin may therefore be critical for 
regulating patterns of energy storage and energy expenditure, and may represent a mechanistic 
pathway through which sleep timing may influence metabolic health and functioning. 
Melatonin may also directly influence nocturnal basal energy expenditure by enhancing 
non-shivering thermogenesis (NST), or the conversion of energy into heat. Non-shivering 
thermogenesis is typically activated in response to cold, diet, or sleep, and accounts for 15-20% 
of total daily energy expenditure in humans (van Marken Lichtenbelt & Schrauwen, 2011). 
Several studies have suggested that melatonin is essential for the activation of NST in brown 
adipose tissue, an organ highly specialized for NST (Heldmaier & Hoffmann, 1974; Skilling et 
al., 2010). In animal models, activated brown adipose tissue has been shown to increase resting 
metabolic rate by 70% (Heim & Hull, 1966; Hayward & Davies, 1972). For several decades, it 
was thought that brown adipose tissue, capable of NST, was only present in humans for the first 
few years of life. Recent studies using PET scans have shown that adults preserve substantial 
amounts of brown adipose tissue which remains metabolically active into adulthood (Tan, 
Manchester, Fuentes-Broto, Paredes, & Reiter, 2011). The aforementioned studies suggest that 
sleep timing may alter nocturnal energy expenditure via melatonin suppression with potential 
downstream consequences for insulin functioning and body weight. 
Melatonin suppression may be more pronounced when light exposure occurs after one’s 
normal bedtime. In a study of healthy young adults, exposure to room light before bedtime 
resulted in a later melatonin onset in 99% of participants and a shortened duration of melatonin 
secretion by an average of 90 minutes (Gooley et al., 2011). The effect of light on melatonin was 
 8 
 
more pronounced when exposure to light coincided with a participant’s self-reported usual sleep 
time. In another study, exposure to incandescent lighting for less than 1 hour during one’s 
normal sleep time was shown to reduce circulating melatonin levels by 50% (Pauley, 2004). 
These studies suggest that intra-week bedtime delay may be an additional indicator of sleep 
timing relevant for metabolic health.     
 
1.3 SLEEP TIMING AND METABOLIC HEALTH IN MIDLIFE WOMEN 
 
Midlife is an optimal time to study the association between sleep timing and metabolic health in 
women, given the accelerated risk for metabolic disturbances, changes in sleep, and circadian 
dysfunction accompanying the menopausal transition. Converging evidence suggests that 
physiological changes during menopause may cause midlife women to be more vulnerable to 
changes in sleep. For instance, the Study of Women’s Health Across the Nation (SWAN) has 
reported that risk for the metabolic syndrome as well as other metabolic risk factors, including 
low-density lipoprotein cholesterol, increase with the menopausal transition (Janssen, Powell, 
Crawford, Lasley, & Sutton-Tyrrell, 2008; Matthews et al., 2009). SWAN investigators have 
also shown that difficulties with sleep latency and sleep maintenance increase across the 
menopausal transition (Kravitz et al., 2008), mediated in part by vasomotor symptoms, changing 
hormone profiles, and waking health behaviors (Sowers et al., 2008; Kravitz et al., 2003; Polo-
Kantola & Erkkola, 2004; Thurston, Santoro, & Matthews, 2012; Kline et al., 2013; Irish, 
Dougall, Delahanty, & Hall, 2013). No study to date has evaluated the influence of sleep timing 
on metabolic health in midlife women.  
 Women in mid-life may also be more sensitive to changes in sleep timing due to changes 
in melatonin synthesis by estrogen and progesterone (Toffol et al., 2013). Melatonin levels are 
known to diminish with age and demonstrate a sharp decline following menopausal onset 
(Walters, Hampton, Ferns, & Skene, 2005). Moreover, melatonin may be less effective in midlife 
due to age-related changes in photosensitivity (Herljevic, Middleton, Thapan, & Skene, 2005). 
Collectively, these studies suggest that sleep timing may be particularly important and 
modifiable health behavior for midlife women.   
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1.4 THE PRESENT STUDY 
 
The sleep and circadian literature provide compelling support for an investigation of day-to-day 
sleep timing and metabolic health. The health consequences of permanent and rotating shift work 
have been well documented. Moreover, the emerging literature on sleep timing and health in the 
general population suggests that further inquiries into this relationship are warranted and that 
longitudinal assessment of this relationship is needed. The present study assessed indices of sleep 
timing, namely average bed time, variability in bed time, bedtime delay and social jetlag in 
relation to metabolic health in midlife women.      
The aim of the present study was to characterize sleep timing in midlife women and to 
evaluate its cross-sectional and prospective associations with indices of metabolic functioning in 
the multi-ethnic cohort of midlife women who participated in the SWAN Sleep Study. Cross-
sectional analyses were used to assess sleep timing in relation to BMI and HOMA-IR measures 
obtained during the core SWAN assessment closest to the SWAN Sleep Study (Time 1). 
Prospective analyses examined indices of sleep timing in relation to BMI and HOMA-IR 
measured at the most recent core SWAN visit (Time 2). Understanding how sleep timing is 
associated with cross-sectional and prospective metabolic outcomes may be used to inform 
behavioral lifestyle interventions and sleep hygiene recommendations.  
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2.0 RESEARCH DESIGN AND METHODS 
 
2.1 PARTICIPANTS AND PROTOCOL 
 
Participants were drawn from the SWAN Sleep Study, an ancillary project to SWAN, a project 
that enrolled a multi-ethnic cohort of midlife women from 7 different sites across the United 
States. Four sites (Pittsburgh, PA; Detroit, MI; Oakland, CA; & Chicago, IL) participated in the 
ancillary Sleep Study, yielding 370 Caucasian, African American and Chinese women. All 
women in the SWAN Sleep Study were either pre-, peri-, or post-menopausal and were between 
the ages of 48-58. Participants provided written informed consent in accordance with guidelines 
put forth by the Institutional Review Boards at each participating institution.  
 Women enrolled in the SWAN Sleep Study completed three nights of in-home overnight 
polysomnography and questionnaire data. Concurrent wrist actigraphy and the Pittsburgh Sleep 
Diary were collected for the duration of the protocol (up to 35 days). Metabolic health data were 
collected during annual core SWAN assessments. Data used in the current analyses were drawn 
from assessments closest to the SWAN Sleep Study (Time 1) and from the most recent and 
available assessment (visit 12; Time 2). 
Exclusion criteria for the SWAN Sleep Study were use of hormone replacement therapy, 
participation in night or shift-work, active chemotherapy or radiation therapy, oral corticosteroid 
use, regular alcohol consumption of more than four drinks per day, or noncompliance with the 
core SWAN protocol. Participants were excluded from the present analysis if they provided less 
than 11 days of SWAN Sleep Dairy data (n = 10) and were excluded from HOMA-IR analyses if 
they were missing blood data at Time 1 (n = 3). Participants were excluded from prospective 
BMI analyses if they were missing BMI from either Time 1 or Time 2 (n = 10) and were 
excluded from prospective HOMA-IR analyses if they were missing blood data from either Time 
1 or Time 2 (n = 65). Additionally, participants were excluded from any analysis for taking 
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insulin or insulin-related medications (n = 22 and 44 for Time 1 and Time 2, respectively). 
Accordingly, sample sizes were 338 and 335 for BMI and HOMA-IR in cross-sectional analyses, 
respectively, and were 306 and 241 for BMI and HOMA-IR in prospective analyses, 
respectively. 
 
2.2. SLEEP TIMING 
 
Clock times for turning out bedroom lights before bed were recorded in Pittsburgh Sleep Diaries. 
Clock times were converted into minutes elapsed from the previous midnight. Average bedtime 
was calculated across the first 14 nights of data collection (11, 12 or 13 days was used for n = 10 
participants). Variability in bedtime was quantified as the standard deviation from an individual’s 
average sleep time, such that, high variability in bedtime was indicated by high standard 
deviations. Social jetlag was calculated as the difference between mid-sleep point on free-days 
and mid-sleep point on non-free days. Consistent with the social jetlag literature, we based non-
free days on the standard Monday through Friday work week. A fourth index of sleep timing was 
calculated to quantify bedtime delay, a proxy for exposure to light following one’s typical 
bedtime. Bedtime delay was calculated as the sum of minutes past average bedtime in a given 
week. Since two weeks of diary data were used to calculate sleep timing variables, we calculated 
bedtime delay for each week and took the average of the two bedtime delay values.   
 
2.3 BODY MASS INDEX 
 
Body mass index (BMI) was calculated as weight in kilograms divided by height in meters 
squared. Body mass index was measured at Time 1 and Time 2 and was used in both cross 
sectional and prospective analyses. Although it is suggested that waist circumference is a better 
predictor of adiposity than BMI (Janssen, Katzmarzyk, & Ross, 2004), we chose to evaluate BMI 
in order to compare and contrast our results with those in the extant literature.   
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2.4 INSULIN RESISTANCE 
 
Homeostasis Model Assessment (HOMA) was used to estimate insulin resistance (Matthews et 
al., 1985). The HOMA method apportions insulin and glucose in terms of sensitivity (resistance 
is the inverse of sensitivity) and yields percentages based on a normal reference population. For 
instance, a HOMA-insulin sensitivity value of .50 would suggest that insulin sensitivity is 
operating at about 50%, which is considered to be relatively low. Subsequently, insulin 
resistance (the inverse of insulin sensitivity) is then estimated to be at about 200%, resulting in a 
HOMA-IR value of 2, which considered relatively high.   
The most recent method (HOMA2) was used for assessing HOMA-IR.  HOMA2 was 
developed by Jonathan Levy in 1998 and adapts the original model (fasting plasma glucose 
(mmol/L) x fasting insulin (mIU/L)/22.5); Matthews et al., 1985) to account for variations in 
hepatic and peripheral glucose resistance, circulating pro-insulin and allows for an insulin 
secretion curve for glucose concentrations above 180 mg/dL (Kong, Chua, & Tow, 1998). The 
HOMA model is comparable to euglycemic-hyperinsulinemic clamp (r = 0.88) for both diabetic 
and non-diabetic individuals (Matthews et al., 1985).   
 
2.5 SAMPLE CHARACTERISTICS AND CANDIDATE COVARIATES 
 
Sample characteristics were derived from the core SWAN assessment closest to the Sleep Study 
or from the Sleep Study itself. These include socio-demographics, such as age, race, and 
education. Candidate covariates were variables known to affect indices of metabolic health. 
Socio-demographic data, medical diagnoses and medication usage were assessed by self-report. 
Menopausal status was based on menstrual bleeding patterns outlined by WHO criteria (World 
Health Organization, 1996). Sleep and nocturnal physiology variables included apnea hypopnea 
index (AHI), total sleep time, sleep latency, and wakefulness after sleep onset. Study site, season 
and years elapsed between Time 1 and Time 2 were also evaluated as additional covariates.   
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2.6 STATISTICAL ANALYSIS 
 
2.6.1 Descriptive Statistics and Covariate Evaluation 
 
Descriptive statistics were used to characterize the study sample according to Aim 1. The 
distributions of sleep timing variables were partitioned into tertiles and participants were 
characterized by early, moderate, or late bedtime groups; low, medium, or high variability, social 
jetlag, and bedtime delay groups. Chi-square statistics and one-way ANOVAs were used to 
characterize the sample across each set of sleep timing groups. Pearson correlations were used to 
identify significant bivariate associations between candidate covariates and both predictor and 
outcome variables. In order to reduce the number of statistical comparisons, only variables with 
significant bivariate associations (p < 0.1) with the primary outcome variables were included as 
covariates in the final statistical models.   
 
2.6.2 Cross-Sectional Analyses 
 
Hierarchical linear regressions were used to test the hypothesis that later sleep time and greater 
variability in sleep time were cross-sectionally associated with sub-optimal metabolic health. 
Relevant covariates were entered into step one for each model. Due to high correlations among 
sleep timing variables (see Appendix Table A1), separate regression models were used for each 
independent predictor. Regression analyses assessed the variance in BMI and HOMA-IR 
explained by each sleep timing variable. 
 
2.6.3 Prospective Analyses 
 
Hierarchical linear regressions were used to test the hypothesis that later bedtime, greater 
variability in bedtime, more social jetlag, and more bedtime delay were prospectively associated 
with sub-optimal metabolic health. All covariates from the cross-sectional analyses were carried 
over and entered into step 1 of the prospective model along with BMI and HOMA-IR values 
from Time 1. Again, separate regression models were used for each independent predictor. 
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Regression analyses assessed the variance in BMI and HOMA-IR accounted for by each sleep 
timing variable while controlling for covariates and measures of metabolic health at Time 1.   
 
2.6.4 Exploratory Analyses  
 
The chronobiological model suggests that the timing of light exposure may be the mechanism 
through which sleep timing influences metabolic health. The current study included data from 
four sites across the country, all of which receive varying degrees of light exposure. Moreover, 
seasonal changes are also associated with varying degrees of light exposure. Therefore, 
moderation analyses were conducted to assess whether cross-sectional or prospective 
relationships between indices of sleep timing and metabolic health varied as a function of study 
site or season during which sleep was measured. Geographical and seasonal differences were 
taken into account to determine whether these factors moderated the sleep timing-metabolic 
health relationship. Additionally, a limited but compelling body of research suggests that 
endogenous circadian rhythms may vary across race and that African Americans may be more 
vulnerable to circadian dysregulation (Lieu, Curhan, Schernhammer, & Forman, 2012; Profant & 
Dimsdale, 1999; Smith, Burgess, Fogg, & Eastman, 2009). Moderation analyses were conducted 
to determine whether the sleep timing-metabolic health relationship varies as a function of race 
in this sample. Finally, given the small number of Chinese women in the sample, sensitivity 
analyses were conducted to assess whether results were independent of their inclusion.   
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3.0 RESULTS 
 
We evaluated associations between measures of sleep timing and indices of metabolic health in 
order to assess the importance of sleep timing to metabolic health in midlife women. Four 
measurements of sleep timing were calculated for the current study: average bedtime, variability 
in bedtime, bedtime delay, and social jetlag. The primary aims of the study were: 1) to 
characterize sleep timing in midlife women across socio-demographic characteristics, measures 
of mental and physical health, and other domains of sleep; 2) to evaluate cross-sectional 
relationships between measures of sleep timing and metabolic health in midlife women; and 3) to 
evaluate prospective relationships between measures of sleep timing at Time 1 and metabolic 
health at Time 2 (average years between time points = 5.39 ± 0.71). We expected later average 
bedtime, greater variability in bedtime, more bedtime delay, and more social jetlag to be 
associated with higher BMI and higher levels of HOMA-IR at Time 1 and Time 2. Several 
exploratory aims were included to evaluate potential modifiers of the sleep timing-metabolic 
health relationship. Specifically, the exploratory aims evaluated whether associations were 
moderated by race, study site, and season.   
A total of 370 women participated in the SWAN Sleep Study. Among them, all had 
complete BMI data and 367 women had complete HOMA-IR data from one of four possible 
annual visits that overlapped with the SWAN Sleep Study. Ten women were excluded from 
analysis due to missing or insufficient Sleep Diary data (less than 11 days; n = 10). Finally, 
participants were excluded if they were taking insulin or medications for type 2 diabetes (n = 
22).  Therefore, cross-sectional analyses were performed using a total sample size of 338 for and 
335 for analyses assessing BMI and HOMA-IR, respectively.  
Participants who were excluded from analyses were more likely to be employed for at 
least 20 hrs/week (χ2 = 5.212; p = .022), report less time engaging in moderate to vigorous 
exercise (F(1, 363) = 7.959; p = .009), have higher self-reported symptoms of depression (F(1, 
367) = 7.614; p = .046), fewer daily servings of alcohol (F(1, 363) = 4.716; p = .028) and have 
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more fragmented sleep F(1, 366) = 2.787; p = .001); see Appendix Table A19). Cross-sectional 
analyses were performed on a sample of 161 Caucasian, 121 African American, and 56 Chinese 
women (age 52.12 ± 2.10). Socio-demographic, health, and sleep characteristics are displayed in 
Table 1. A substantial portion of the sample was either married or living with a partner (n = 219; 
65.75%), had a college degree (n = 174; 52.29%) or worked more than 20 hours per week (n = 
270; 79.88%). Marital status (χ2 = 26.186; p < .001) and education (χ2 = 21.860; p < .001) tended 
to vary by race (see Table 1).   
On average, the sample was overweight (BMI = 29.55 ± 7.57) with HOMA-IR values 
within the normal range (1.73 ± 1.29; see Table 1; Wahrenberg et al., 2005). About two thirds of 
the sample were peri- or early peri-menopausal (n = 211, 63%). On average, participants 
reported vasomotor symptoms, such as hot flashes or night sweats, on 32.84% (± 33.92) of study 
days and reported exercising on 20.84% (± 23.89) of study days. The sample contained few 
smokers (n = 34, 10.06%) and on average, participants consumed 0.29 (± 0.50) servings of 
alcohol and 1.6 (± 1.37) servings of caffeine per day while participating in the study. Average 
symptoms of depression were low (4.65 ± 2.78). Almost all health characteristics varied by race 
(see Table 1). Specifically, BMI and HOMA-IR values were significantly higher among African 
American women compared to Caucasian, (t(335) = -5.141; p < .001 and t(332) = -4.665; p < 
.001) or Chinese women (t(335) = 9.150; p < .001 and t(332) = 3.577; p < .001). African 
American women also reported more frequent vasomotor symptoms and were more likely to be a 
current smoker than Caucasian (t(335) = -3.941; p < .001and t(280) = -2.970; p = .003) or 
Chinese women (t(335) = 3.135; p = .002 and t(175) = -5.307; p < .001). Caucasian women 
reported higher alcohol and caffeine consumption compared to African American (t(335) = 
5.492; p < .001 and t(335) = 6.601; p < .001) and Chinese women (t(335) = 4.508; p < .001 and 
t(335) = 4.504; p < .001). Caucasian women also reported more frequent moderate to vigorous 
exercise than African American women (t(335) = 3.626; p < .001). Finally, symptoms of 
depression varied by race (F(2,220) = 7.99; p < .001), with African American women reporting 
more depression than either Caucasian women (t(335) = -2.657; p = .008) or Chinese women 
(t(335) = 2.378; p = .011).      
Average sleep duration in the current sample was a little over 6 hours (6.23 hrs ± 55.51 
mins). Participants spent an average of 21.19 minutes (SD = 20.51) trying to fall asleep and 
52.71 minutes (SD = 30.87) awake after sleep onset. Sleep complaints measured by the 
 17 
 
Pittsburgh Sleep Quality Index (PSQI) were high (5.64 ± 3.06). Sleep disordered breathing, 
measured by apnea hypopnea index, was relatively low (8.05 ± 9.07), and women reported 
taking sleep medication on an average of 25.70% of study nights. Race differences were 
significant across several sleep measures, as previously reported (Hall et al., 2009). In general, 
African American women had shorter sleep duration, took longer to fall asleep, and spent more 
time awake after sleep onset (see Table 1).     
Participants reported an average bedtime of 11:30 pm (SD = 59.27 mins), variability in 
bedtime of about 56 minutes (SD = 32.22 mins), bedtime delay of 138.27 minutes (SD = 56.48 
mins) and social jetlag of about 42.71 minutes (SD = 43.11 mins; see Table 1). Sleep timing 
variables were partitioned into tertiles and rounded to the nearest half hour to create three groups 
per variable. Demographic, health, and sleep characteristics were examined across sleep timing 
groups. One-way ANOVAs and chi-square tests were used to assess significant differences 
across sleep timing categories. Follow-up t-tests were performed when omnibus tests were 
significant. Continuous sleep timing variables were used in follow-up t-tests to dissect significant 
chi-square results.   
 
3.1 SOCIO-DEMOGRAPHIC CORRELATES OF SLEEP TIMING 
 
Racial differences were found among average bedtime (χ2 = 14.282; p = .006), variability in 
bedtime (χ2 = 31.049; p < .001), and bedtime delay (χ2 = 24.497; p < .001) and are presented in 
Figure 2. Caucasian women were more likely to have an early bedtime compared to African 
American (t(280) = -2.937; p = .004) and Chinese women (t(152) = -2.431; p=.016). African 
American women were more likely to have higher variability in bedtime and greater bedtime 
delay compared to Caucasian women (t(280) = -5.195; p < .001 and t(280) = -4.895; p < .001, 
respectively) and compared to Chinese women (t(175) = -3.263; p = .001 and t(175) = -4.384; p 
< .001, respectively). Sleep timing also tended to vary by marital status and education. Women 
who were married or living with a partner had lower variability in bedtime and less bedtime 
delay than women who were single (t(336) = -2.779; p = .006 and t(336) = -2.491; p = .013, 
respectively). Similarly, women with a college degree had lower variability in bedtime and less 
bedtime delay than women without a college degree (t(330) = -2.988; p = .003 and t(330) = -
3.740; p < .001, respectively). Finally, women who were employed for at least 20 hours/week 
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had significantly more social jetlag than women who were unemployed or underemployed had 
lower variability in bedtime and less bedtime delay than women who were single (t(336) = -
3.115; p = .002). These associations were not moderated by race (p-values > .05).     
 
3.2 HEALTH CORRELATES OF SLEEP TIMING 
 
Health behaviors and measures of both mental and physical health varied by sleep timing groups. 
Women with the latest bedtimes reported significantly less time exercising compared to those in 
the early bedtime group (t(335) = 2.460; p = .014; see Table 2). Reported frequency of 
vasomotor symptoms was also highest among women with the latest bedtimes (F(2,337) = 4.560, 
p = .011) and the least amount of social jetlag (F(2,337) = 4.124, p = .017). Finally, depression 
scores were significantly higher among women with the latest bedtimes (F(2,337) = 3.568, p = 
.029), the highest variability in bedtime (F(2,337) = 5.804, p = .003) and the most bedtime delay 
(F(2,337) = 6.025, p = .003). No associations between sleep timing and health characteristics 
were moderated by race (p-values > .05). 
 
3.3 SLEEP CORRELATES OF SLEEP TIMING 
 
Sleep latency and sleep quality also differed by sleep timing groups. Specifically, early bedtime 
and moderate social jetlag were both associated with shorter sleep latency (F(2,337) = 3.873, p = 
.022 and F(2,337) = 3.689, p = .026, respectively; see Tables 2 and 5). Subjective sleep 
complaints were highest among those with the latest bedtimes, the greatest variability in bedtime 
and the most bedtime delay (F(2,337) = 3.898, p = .021; F(2,337) = 4.260, p = .015 and F(2,337) 
= 5.869, p = .003, respectively). Associations between sleep timing and sleep were independent 
of race effects (p-values > .05).      
 
3.4 COVARIATE SELECTION 
 
After assessing the relationships between relevant covariates and the outcome measures, 5 and 6 
covariates were included in the final cross-sectional models predicting BMI and HOMA-IR, 
respectively. These covariates included race, menopausal status, exercise, depression and sleep 
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duration. Body mass index was also controlled for in models predicting HOMA-IR. In 
prospective analyses, metabolic health variables at Time 1 were also controlled for. Study site, 
season nor time elapsed between Time 1 and Time 2 were associated with metabolic health 
variables and were therefore not included in the models. 
 
3.5 CROSS-SECTIONAL ASSOCIATIONS BETWEEN SLEEP TIMING AND BMI 
 
As shown in Table 6, several unadjusted cross-sectional associations between sleep timing and 
BMI were significant. Specifically, greater variability in bedtime and more bedtime delay were 
associated with higher BMI (β = .188; p = .001 and β = .258; p < .001, respectively). After 
controlling for race, menopausal status, sleep duration, exercise and depression, the relationship 
between bedtime delay and BMI remained significant (β = .128; p = .010). Race, exercise, 
depression and sleep duration were also significant predictors of BMI (see Appendix Tables A2-
A5). 
 
3.6 CROSS-SECTIONAL ASSOCIATIONS BETWEEN SLEEP TIMING AND 
HOMA-IR 
 
In unadjusted models presented in Table 7, variability in bedtime and bedtime delay were both 
associated with the HOMA-IR (β = .259; p <.001 and β = .258; p < .001, respectively). 
Variability in bedtime and bedtime delay remained statistically significant after adjusting for 
race, menopausal status, sleep duration, exercise, depression, and BMI (β = .132; p = .005 and β 
= .098; p = .038, respectively). Variability in bedtime and bedtime delay explained an additional 
1.5% and 0.8% of the variance in HOMA-IR, respectively, above and beyond other variables in 
the model. Average bedtime and social jetlag were unrelated to HOMA-IR before and after 
adjustment (p > .05). Other significant predictors of HOMA-IR included race and BMI (see 
Appendix Tables, A6-A9). 
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3.7 PROSPECTIVE ASSOCIATIONS BETWEEN SLEEP TIMING AND 
METABOLIC HEALTH 
 
Of the 338 women included in cross-sectional analyses, 20 were lost to follow-up, 65 women 
were missing HOMA-IR data at Time2, and 12 started taking insulin-related medication. 
Prospective analyses were run using 306 and 241participants for BMI and HOMA-IR outcomes, 
respectively. Means and correlations between BMI and HOMA-IR values at Time 1 and Time 2 
are presented in Appendix Table A18.  There was a significant increase in BMI between Time 1 
and Time 2, t(320)= -3.228, p = .001. There was no significant change in HOMA-IR across time, 
t(262)= .380, p = .704. All covariates from cross-sectional analyses were carried over to 
prospective analyses with the addition of metabolic health measures at Time 1. Time between 
assessments was evaluated as a covariate for prospective relationships but was not included due 
to lack of association with outcome variables.         
As seen in Table 8, unadjusted prospective associations were found between several 
measures of sleep timing and BMI at Time 2. However, after adjusting for race, menopausal 
status, sleep duration, exercise, depression, and BMI at Time 1, relationships between sleep 
timing and BMI at Time 2 were no longer present. Bedtime delay was associated with HOMA-
IR at Time 2 in unadjusted models. However, no index of sleep timing predicted HOMA-IR at 
Time 2 after adjusting for covariates and HOMA-IR values at Time 1 (Table 9).  
 
3.8 AD-HOC EXPLORATORY ANALYSES 
 
3.8.1 Do associations between sleep timing and metabolic health vary by study site or 
season?  
 
The current study used bedtime as a behavioral proxy for exposure to light at night.  However, 
other factors can influence light exposure. For instance, in the current sample, light exposure 
would likely vary across study site and across season. Exploratory analyses were conducted to 
assess whether associations among sleep timing and metabolic health varied as a function of 
these two variables. Moderation analyses were conducted to evaluate whether results varied 
between participants in Oakland, California and participants studied at other locations.  Results 
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revealed no significant interaction with study site (data not shown). Due to the ancillary nature of 
the sleep study, metabolic health data and sleep timing data were collected at different points in 
time, and it was not possible to assess moderation by season. For instance, metabolic health and 
sleep timing were measured during the same season in only 28.5% of the sample (n = 63). 
Among those participants, only 39.7% had concurrent measures during the same month (n = 25).  
 
3.8.2 Do associations between sleep timing and metabolic health vary by race?  
 
Given significant differences in sleep timing between race groups, additional analyses were 
conducted to assess whether relationships between sleep timing and metabolic health variables 
varied as a function of race. Moderation analyses were conducted by entering sleep-timing by 
race interaction terms into the regression models. No cross-sectional or prospective associations 
between sleep timing and metabolic health varied as a function of race (data not shown). 
 
3.8.2.1 Sensitivity Analysis Given the small number of Chinese women in the sample, a 
sensitivity analysis was conducted to determine whether results remained significant after 
removing Chinese women. Sensitivity analysis preserved nearly all associations identified in the 
original model. However, the cross-sectional association between bedtime delay and insulin 
resistance was no longer significant after excluding Chinese women (β = .007; p = .081; See 
Table 10).     
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4.0 DISCUSSION AND CONCLUSIONS 
 
Epidemiological studies of shift work and experimental circadian dysregulation protocols have 
demonstrated that highly irregular sleep timing has adverse consequences for metabolic health. 
However, this is the first study to assess whether moderate differences in sleep timing are 
associated with metabolic health in a normative population, using naturalistic parameters of sleep 
timing and both cross-sectional and longitudinal outcomes. We examined cross-sectional (N = 
338) and prospective (N = 306) relationships between four measures of sleep timing and two 
indices of metabolic health in a multi-ethnic cohort of midlife women. Fully adjusted cross-
sectional analyses revealed a significant association between day-to-day variability in bedtime 
and insulin resistance, such that greater variability was associated with higher HOMA-IR values.  
Moreover, cross-sectional analyses also showed that bedtime delay was associated with both 
BMI and HOMA-IR, such that more bedtime delay was associated with higher BMI and greater 
HOMA-IR after controlling for race, menopausal status, sleep duration, exercise, depression, and 
BMI. Prospective analyses yielded no significant relationships between sleep timing and 
metabolic health after adjusting for covariates. These data indicate that individual differences in 
sleep timing are associated with metabolic health in a non-shift working population. The current 
findings provide partial support for a chronobiological model linking sleep timing with metabolic 
health.  
Sleep timing acts as a behavioral marker for the extent to which people are exposed to 
light before sleep. We propose that sleep timing may act on health outcomes via a melatonergic-
metabolic pathway by gating the effect of light on circadian signaling. Light at night is known to 
suppress melatonin. Converging evidence indicates that melatonin plays a vital role in regulating 
the daily rhythm in glucose tolerance and that melatonin suppression may have consequences for 
energy homeostasis (Picinato, Haber, Carpinelli, & Cipolla-Neto, 2002; Nishida, Sato, Murai, & 
Nakagawa, 2003; Pimenta, Kac, Souza, Ferreira, & Silqueira, 2012). In particular, melatonin is 
thought to bind with receptors on the pancreas and liver to inhibit the production of insulin and 
inhibit hepatic gluconeogenesis, thereby allowing stored glucose in liver and muscle tissues to 
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re-enter the blood stream for metabolic use, otherwise known as the catabolic or energy 
expenditure phase of digestion (Faria et al., 2013). Light at night is therefore thought to delay 
this catabolic phase of digestion and promote a prolonged anabolic phase of energy storage. As 
described earlier, rhythmic patterns of energy storage and energy usage are needed to maintain 
energy homeostasis. When the anabolic phase of digestion is prolonged, glycogen stores become 
full and extra glucose is stored in adipose tissue as fat or is maintained in the blood stream 
resulting in a hyperglycemic state. Chronic exposure to light at night could eventually result in 
weight gain and dysregulated glucose metabolism via insulin. We predicted that habitual sleep 
timing patterns would be associated with BMI and HOMA-IR.        
Bedtime delay was associated with higher BMI and greater HOMA-IR in cross-sectional 
analyses. This finding is consistent with our model and with the literature. Bedtime delay may 
have direct effects on melatonin suppression through extended light exposure after when one 
would usually be asleep. For instance, melatonin suppression by light has been shown to be 
stronger when the light exposure occurs during usual sleeping hours (Gooley et al., 2011).  
Bedtime delay may even have consequences for melatonin after light is no longer directly 
inhibiting secretion. For instance, duration and intensity of light exposure at night has been 
shown to be inversely associated with nocturnal melatonin levels during sleep (Aoki, Yamada, 
Ozeki, Yamane, & Kato, 1998) and studies of permanent night work suggest that chronic 
melatonin suppression may have long term consequences for pineal functioning and melatonin 
production (Barbadoro et al., 2013). Findings from the animal literature also indicate that 
reduced melatonin levels may also impact BMI by limiting the efficacy of weight loss efforts. 
Specifically, low nocturnal melatonin has been shown to blunt adipose tissue response to aerobic 
exercise and fasting in rodent models (Borges-Silva et al., 2007; Borges-Silva et al., 2005; 
Alonso-Vale et al., 2004).   
Variability in bedtime was significantly associated with increased HOMA-IR, cross-
sectionally. This finding is consistent with the two other studies of sleep timing and health that 
have been conducted in non-shift workers that found that higher variability in bedtime was 
associated with greater risk for obesity (Logue et al., 2014b; Bailey et al., 2014b). Our finding is 
also consistent with our model and suggests that high variability in bedtime may be analogous to 
inconsistent circadian signaling. A review by Van Someren & Riemersma-Van Der Lek (2007) 
suggests that internal synchrony among peripheral clocks is achieved by sustained and regular 
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24-hour patterns of input from environmental zeitgebers (Van Someren & Riemersma-Van Der 
Lek, 2007). The authors of this review provide a metaphor of an adult pushing a child on a swing 
to illustrate the effect of time cues on peripheral pacemakers. Zeitgebers, or time cues, are 
represented by the adult in this metaphor, providing regular input to maintain oscillations in 
peripheral pacemakers. As the authors state, children can move the swing back and forth on their 
own by systematically raising and lowering their center of mass. However, their ability to 
maintain a robust rhythm depends on their mastery of swinging, or the endogenous strength of 
the peripheral oscillator.    
Light is the most salient zeitgeber that entrains the circadian system by directly regulating 
melatonin, the most robust neuroendocrine signal of the circadian timing system or the “arm” of 
the biological clock (Mirick & Davis, 2008). From tightly controlled animal studies, we know 
that the absence of a zeitgeber, such as light, can lead to dampening and eventually halting 
oscillations in peripheral tissues. Moreover, abrupt shifts in light exposure can result in 
desynchrony between pacemakers, such as those in the liver and adipose tissue (Young, 2006; 
Yamazaki et al., 2000). Clock genes in the liver and adipose tissue rely on external cues to 
maintain the translational and transactional negative feedback loops that regulate glucose 
homeostasis and processes of energy mobilization (la Fleur, Kalsbeek, Wortel, Fekkes, & Buijs, 
2001; Alonso-Vale et al., 2004). Therefore, variability in bedtime may impair metabolic health 
via irregular circadian input.  
The association between variability in bedtime and insulin resistance is also consistent 
with the shift work literature. Although permanent night-shift work and rotating night-shift work 
have both been associated with adverse health outcomes, several studies have reported that 
rotating shift work is associated with worse subjective well-being (Alward & Monk, 1990), a 
higher prevalence of cardiovascular risk factors (Moore-Ede & Richardson, 1985; Knutsson, 
Akerstedt, & Jonsson, 1988; Thelle, Foorde, Try, & Lehmann, 1976; Theorell & Akerstedt, 
1976), and greater risk for certain types of cancer (Papantoniou et al., 2014). Variability in the 
timing of behaviors such as sleep may help to explain increased relative risk among rotating shift 
workers compared to permanent night shift workers. 
Alternative explanations for the significant associations between indices of sleep timing 
and metabolic health should also be considered. For instance, bedtime delay could be associated 
with eating later at night while variability in bedtime could be associated with variability in 
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eating time (Spaeth, Dinges, & Goel, 2013). In the absence of one zeitgeber, such as light, the 
circadian system has been known to rely on other time cues to maintain regular oscillation. For 
instance, in the absence of a light/dark cycle, rodents will entrain to food availability (Holmes & 
Mistlberger, 2000; Yokoi et al., 2002). The significance of food-entrained oscillation may be 
particularly important for peripheral clocks of those organs involved in glucose metabolism and 
insulin production such as the liver and the pancreas (Damiola et al., 2000; Stokkan, Yamazaki, 
Tei, Sakaki, & Menaker, 2001; Ekmekcioglu & Touitou, 2011). For instance, circadian genes 
such as BMAL and PER2, appear to be preferentially sensitive to different circadian time cues 
(Saini et al., 2013). BMAL and PER2 are both entrained by light; however, PER2 is highly 
sensitive to food intake and macronutrient content (Sherman et al., 2012).   
Follow-up analyses were conducted to assess whether indices of meal timing explained 
significant associations between sleep timing and metabolic health. Dinner time was not 
associated with cross-sectional measures of BMI after controlling for covariates (ΔR2= .004; β = 
.061; p = .216) and did not attenuate significant associations between bedtime delay and BMI. 
Similarly, variability in bedtime was robust to adjustment for variability in dinner time, which 
did not account for a significant proportion of the variance after adjustment for covariates (ΔR2 = 
.003; β = .056; p = .251). In our sample, measures of meal timing did not explain associations 
between sleep timing and metabolic health. However, future studies should employ tightly 
controlled methods to parse out the relative influence of sleep timing and meal timing and how 
they might interact with one another. It should also be noted that indices of sleep timing could 
also reflect employment and lifestyle characteristics. Future studies should examine predictors of 
sleep timing such as elective work hours, domestic and familial responsibilities, features of 
chaotic lifestyles (Patel et al., 2014) and mood disorder symptomatology (Harvey, 2009).   
Contrary to expectations, later average bedtime was not associated with higher BMI or 
greater HOMA-IR in either cross-sectional or prospective analyses. This may be considered 
inconsistent with our model of melatonin suppression. However, this null finding may also 
suggest that later average bedtime may reflect a later endogenous circadian rhythm and later 
melatonin onset. Therefore, light exposure during the time before one would normally go to bed 
would not act on the circadian system to suppress melatonin in the same way that light exposure 
past one’s average bedtime would. Future studies should examine the congruence between 
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endogenous circadian rhythms and behavioral rhythms and examine the downstream effects on 
metabolic physiology. 
Social Jetlag was also unrelated to either HOMA-IR or BMI at either time point. 
However, this null finding was likely due to the limited amount of social jetlag in the sample. 
Participants demonstrated an average social jetlag of 42.71 minutes (SD = 43.11 minutes). 
Previous studies of social jetlag have identified increased risk for metabolic health problems with 
greater than or equal to 2 hours of social jetlag (Roenneberg et al., 2012). In the current sample, 
only 5.33% (n = 18) had a social jetlag of 2 hours or more at Time 1. Moreover, social jetlag in 
this sample ranged from -115.08 to 162.05 minutes. This range indicates that 13.90% of the 
sample had a later mid-sleep point on week days compared to weekends, suggesting that some 
participants may not have worked a Monday-Friday schedule. Consistent with previous social 
jetlag studies, we based free days and non-free days on the standard five-day work week. Future 
studies should directly assess participants’ schedules. 
In light of the current findings, we might consider revising the model to differentiate 
between sleep timing variables that measure extent of exposure to light at night and inconsistent 
exposure to light at night. For instance, bedtime delay may be more appropriate measures to test 
a melatonin suppression model which may be adequate to assess risk for weight gain, given the 
strong research linking adipose accumulation and adipose dysfunction in the absence of 
melatonin described above. Conversely, variability in bedtime may be associated with 
desynchrony between multiple peripheral pacemakers located in different physiological systems. 
Intermittent or unpredictable zeitgeber exposure may prevent entrainment and interrupt signaling 
cascades that are needed to maintain synchrony across peripheral clocks (Van Someren & 
Riemersma-Van Der Lek, 2007). 
The effect sizes for significant associations between sleep timing and metabolic health 
were all quite small. Specifically, bedtime delay explained 1.4% of the variance in BMI at Time 
1 which is comparable to or greater than other correlates of BMI identified in the extent literature 
such as age, menopausal status, education, number of children and smoking (Matthews et al., 
2001). However, the effect size for bedtime delay is considerably lower than other correlates of 
BMI such as race, physical activity and indices of sleep (Matthews et al., 2001; Mezick, 
Matthews, Hall, Richard, & Kamarck, 2014). Similarly, variability in bedtime and bedtime delay 
explained 1.5% and 0.8% of the variance in HOMA-IR, respectively. These effect sizes are 
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significantly lower than those for correlates of HOMA-IR such as physical activity, smoking or 
depression (Jeffery, Babeu, Nelson, Kloc, & Klette, 2013; Slagter et al., 2013; Kan et al., 2013).  
The small effect sizes found within the current set of results indicate that although sleep timing is 
significantly associated with metabolic health, the clinical relevance of sleep timing for these 
measures may be limited. Additional testing is needed to understand the importance of sleep 
timing within the context of other health behaviors.           
Several limitations of the current study are worth addressing. Within this study, sleep 
timing variables were used as a behavioral marker to approximate exposure to light at night; 
however, direct measurement of light exposure was not conducted within this study. Therefore, 
we were unable to determine whether light exposure mediated associations among sleep timing 
and metabolic health. Direct measurement of light is needed in order to fully understand its 
effects on melatonin suppression and subsequent metabolic processes. For instance, in addition 
to simply exposure, studies have shown that there is a dose-response relationship between the 
intensity of light at night and melatonin suppression (Boivin, Duffy, Kronauer, & Czeisler, 1996; 
McIntyre, Norman, Burrows, & Armstrong, 1989). Measurements of ambient light intensity may 
therefore provide vital information for understanding the role of sleep timing in metabolic health. 
Additionally, individual differences in melatonin secretion and sensitivity to light at night should 
also be taken into consideration (Lindsay et al., 2002). Objective measurement of melatonin is 
needed to more accurately test the proposed melatonergic-metabolic model. Dim-light melatonin 
onset values should be measured among participants in order to understand when melatonin 
suppression by light would/could take place. 
Measurements of metabolic health and sleep data were not concurrent. Because the 
SWAN Sleep Study was ancillary to SWAN, measurements of metabolic health and sleep were 
often taken at different time points. This limits our ability to draw conclusions from these 
analyses. Sleep timing is likely variable across many circumstances including changing seasons. 
Seasonal differences alter exposure to light via length of day which may have implications for 
sleep timing, as well as other behaviors relevant to metabolic health. Concurrent measures at 
multiple time points are needed to better understand the acute effects of sleep timing on 
metabolic health as well as how relationships between sleep timing and health influence each 
other over time. 
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Prospective analyses did not take into account changes in sleep timing from Time 1 to 
Time 2. We conducted reliability tests to assess the stability of our sleep timing measures. 
Several sleep timing variables demonstrated excellent reliability between Time 1 and Time 2. 
Specifically, average bedtime and variability in bedtime remained very stable among participants 
across time points, intra-class correlation coefficients were .900 (95% CI: .876 - .919) and .939 
(95% CI: .925 - .951), respectively. Bedtime delay demonstrated acceptable reliability while 
social jetlag demonstrated poor reliability with intra-class correlation coefficients of .606 (95% 
CI: .506 - .685) and .096 (95% CI: -.122 - .271), respectively (Streiner, 1995). Therefore, it is 
possible that bedtime delay and social jetlag are not stable over time in midlife women. Short-
term reliability was also assessed to determine how stable sleep timing variables were between 
weeks 1 and 2 of diary data collection. Average bedtime demonstrated strong short-term 
reliability with an intra-class correlation coefficient of .888 (95% CI: .863 - .909). Variability in 
bedtime and bedtime delay demonstrated reliability within the acceptable range with intra-class 
correlation coefficients of .569 (95% CI: .470 - .649) and .578 (95% CI: .481 - .656), 
respectively. Measures of social jetlag demonstrated poor short-term reliability between weeks 1 
and 2 with an intra-class correlation coefficient of .391(95% CI: .252 - .505). Due to the low 
short-term reliability demonstrated here, the current results must be interpreted with caution. 
These reliability statistics demonstrate that a longer window of observation is needed to 
understand habitual sleep timing variables and assess whether people demonstrate stable sleep 
timing profiles across periods of time.    
The limitations of the current study are offset by several notable strengths. Both SWAN 
and the SWAN Sleep Study sampled from a diverse population of multi-ethnic women, allowing 
us to look at race differences among the associations between sleep timing and metabolic health. 
Given the race disparities seen across metabolic health outcomes, race moderation analyses are 
warranted to gain a better understanding of the bio-behavioral pathways through which 
disparities might arise. Moreover, sleep timing was measured over the course of at least 11 full 
days (14 full days in 94.08% of subjects). Studies of habitual sleep timing have largely used 
single item questionnaires to probe typical bed and wake times on work and non-work days. The 
use of the Pittsburgh Sleep Diary allowed us to track sleep timing without the limitation of recall 
bias. Lastly, we used objective measures of metabolic health at multiple time points. The 
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homeostasis model assessment of insulin resistance and BMI allowed us to look at sleep timing 
in relation to a continuous gradient of risk for metabolic health problems. 
In summary, the current study provided preliminary support for a melatonergic-metabolic 
pathway linking sleep timing with metabolic health. As indicated above, future studies would 
benefit from measuring ambient light exposure using objective means. Many actigraph devices 
are now equipped with light-sensing capability. Enhanced devices such as the Actiwatch 
Spectrum are able to collect light data from multiple channels such as photopic white light 
illuminance and red, green and blue light irradiance. Detailed information regarding ambient 
light exposure would inform our understanding of how sleep timing and other pre-sleep behavior 
(e.g., reading, watching TV) contributes to circadian functioning. Moreover, an objective 
measure of melatonin secretion is needed in future studies of habitual sleep timing. Dim-light 
melatonin onset provides a measure of the endogenous circadian rhythm of melatonin in the 
absence of time cues such as light. The timing of endogenous melatonin secretion is needed to 
understand when the production of melatonin would be interrupted by light exposure. Finally, 
experimental manipulations of sleep timing are needed to evaluate observed associations under 
controlled circumstances and assess the impact of melatonin suppression on downstream 
metabolic physiology. The current study warrants a systematic evaluation of light exposure and 
melatonin suppression as a mechanistic pathway through which sleep timing may influence 
metabolic health.    
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Table 1 
 Sample characteristics by race 
  Race  
 Total 
(n = 338) 
Caucasian 
(n = 161) 
African American 
(n = 121) 
Chinese 
(n = 56) 
Sig 
Demographic Characteristics 
Age mean(sd) 52.12±2.10 52.17±2.11 51.83±2.07 52.57±2.12 .083 
Marital Status 
   Married/living w/ partner N(%) 
 
219(65.75) 
 
122(75.78) 
 
57(47.11) 
 
40(71.43) 
 
<.001*** 
Education 
   ≥ college degree N(%) 
 
174(52.29) 
 
98(60.87) 
 
41(33.88) 
 
35(62.50) 
 
<.001*** 
Employment 
   Unemployed or <20 hrs/wk N(%) 
 
68(18.96) 
 
29(18.01) 
 
28(23.14) 
 
11(19.64) 
 
.566 
Menopausal Status 
   Peri/early peri-menopausal N(%) 
 
211(63.00) 
 
105(65.22) 
 
71(58.68) 
 
35(62.50) 
 
.512 
Health Characteristics 
BMI mean(sd) 29.55±7.57 29.01±6.82 33.20±7.91 23.19±2.74 <.001*** 
HOMA-IR (N=335) mean(sd)  1.73±1.29 1.47±0.82 2.23±1.81 1.37±0.51 <.001*** 
Current smoker N(%) 34(10.06) 11(6.83) 23(19.01) 0(0.00) <.001*** 
Caffeine consumption mean(sd) 1.57±1.37 2.08±1.49 1.07±0.95 1.19±1.25 <.001*** 
Alcohol consumption mean(sd) 0.29±0.50 0.46±0.61 0.14±0.33 0.12±0.28 <.001*** 
% days mod/vig exercise mean(sd) 20.84±23.89 25.60±24.22 15.35±21.76 18.98±24.91 .001** 
% days vms mean(sd) 32.84±33.92 27.40±29.86 43.11±36.48 26.32±34.50 <.001*** 
IDS mean(sd) 4.65±2.78 4.37±2.30 5.25±3.23 4.11±2.84 .009** 
STAI mean(sd) 15.28±4.45 15.16±4.13 15.43±4.71 15.27±4.79 .878 
Sleep Characteristics 
Duration mean(sd) 373.86±55.51 385.96±48.95 352.91±62.85 384.18±42.46 <.001*** 
Wakefulness after sleep onset(sd) 52.71±30.87 49.93±26.11 60.20±37.58 44.60±23.75 .002** 
Latency 21.19±20.51 18.98±16.57 26.98±26.75 15.09±9.80 <.001*** 
PSQI 5.64±3.06 5.04±2.61 6.63±3.51 5.18±2.72 <.001*** 
AHI 8.05±9.07 8.56±9.80 7.73±8.58 7.27±7.84 .599 
% days sleep meds 25.70±42.58 27.88±43.71 23.66±41.39 23.88±42.30 .671 
Average Bedtime 11:30pm±59.27mins 11:19pm±56.06mins 11:40pm±66.08mins 11:39pm±48.58mins .005** 
Variability in Bedtime 56.34±32.22 48.49±24.85 70.44±38.94 50.89±27.04 <.001*** 
Bedtime Delay 138.27±56.48 127.47±53.43 160.37±58.97 121.57±44.18 <.001*** 
Social Jetlag 42.71±43.11 45.84±43.11 40.04±44.50 39.47±40.07 .443 
*p < .05. **p < .01. ***p < .001. 
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Table 2  
Demographic, health and sleep characteristics across early, moderate and late bedtime categories 
                           Average Bedtime  
 Early  
(n=100) 
Moderate 
(n=155) 
Late 
(n=83) 
Sig 
Demographic Characteristics 
Age mean(sd) 52.15±2.05 52.11±2.10 52.09±2.19 .978 
Race 
   White N(%) 
   Black N(%) 
   Chinese N(%) 
 
58(58.00) 
28(28.00) 
14(14.00) 
 
77(49.68) 
56(36.13) 
22(14.19) 
 
26(31.32) 
37(44.58) 
20(24.10) 
 
.006** 
Marital Status 
   Married/living w partner N(%) 
 
68(68.00) 
 
97(62.58) 
 
54(65.06) 
 
.675 
Education 
   ≥ college degree N(%) 
 
52(52.00) 
 
86(55.48) 
 
36(43.37) 
 
.190 
Employment 
   Unemployed or <20 hrs/wk N(%) 
 
13(13.00) 
 
34(21.94) 
 
21(25.30) 
 
.088 
Menopausal Status 
   Peri/early peri-menopausal N(%) 
 
61(61.00) 
 
102(65.81) 
 
48(57.83) 
 
.319 
Health Characteristics 
BMI mean(sd) 28.59±6.52 29.83±7.54 30.18±8.69 .302 
HOMA-IR (N=335) mean(sd) 1.64±1.20 1.65±1.23 1.98±1.49 .164 
Current smoker N(%) 7(7.00) 17(10.97)  10(12.04) .463 
Caffeine consumption mean(sd) 1.39±1.24 1.68±1.41 1.57±1.42 .260 
Alcohol consumption mean(sd) 0.31±0.59 0.32±0.48 0.20±0.42 .165 
% days mod/vig exercise mean(sd) 24.25±26.40 21.41±23.20 15.65±21.24 .048* 
% days vms mean(sd) 31.99±33.53 28.42±32.36 42.14±35.77 .011* 
IDS mean(sd) 4.19±2.27 4.60±2.95 5.28±2.93 .029* 
STAI mean(sd) 15.01±4.07 15.09±4.51 15.94±4.73 .287 
Sleep Characteristics 
Duration mean(sd) 377.30±54.70 377.83±50.56 362.20±63.89 .091 
Wakefulness after sleep onset(sd) 52.27±31.54 51.57±29.24 55.38±33.19 .657 
Latency 17.02±11.07 21.62±20.22 25.40±27.85 .022* 
PSQI 5.39±2.64 5.36±3.12 6.45±3.31 .021* 
AHI 7.17±6.91 8.27±9.40 8.75±10.66 .479 
% days sleep meds 19.35±38.20 26.59±42.85 31.70±46.44 .140 
*p < .05. **p < .01. ***p < .001. 
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Table 3 
Demographic, health and sleep characteristics across high, moderate and low bedtime variability categories 
                      Variability in Bedtime 
 Low 
(n=104) 
Moderate 
(n=119) 
High 
(n=115) 
Sig 
Demographic Characteristics 
Age mean(sd) 52.27±1.90 52.09±2.03 51.97±2.11 .557 
Race 
   White N(%) 
   Black N(%) 
   Chinese N(%) 
 
65(62.50) 
19(18.27) 
20(19.23) 
 
57(47.90) 
40(33.61) 
22(18.49) 
 
39(33.91) 
62(53.91) 
14(12.17) 
 
<.001*** 
Marital Status 
   Married/living w partner N(%) 
 
74(71.15) 
 
81(68.07) 
 
64(55.65) 
 
.037* 
Education 
   ≥ college degree N(%) 
 
65(62.50) 
 
63(52.94) 
 
46(40.00) 
 
.004** 
Employment 
   Unemployed or <20 hrs/wk N(%) 
 
17(16.35) 
 
25(21.01) 
 
26(22.61) 
 
.491 
Menopausal Status 
   Peri/early peri-menopausal N(%) 
 
65(62.50) 
 
76(63.87) 
 
70(60.87) 
 
.717 
Health Characteristics 
BMI mean(sd) 28.19±6.63 29.07±7.14 31.27±8.47 .007** 
HOMA-IR mean(sd) 1.39±0.85 1.64±0.96 2.10±1.72 .001** 
Current smoker N(%) 7(6.73) 10(8.40) 17(14.78) .107 
Caffeine consumption mean(sd) 1.70±1.36 1.53±1.35 1.49±1.39 .481 
Alcohol consumption mean(sd) 0.39±0.59 0.24±0.42 0.26±0.48 .059 
% days mod/vig exercise mean(sd) 22.54±23.78 21.75±26.11 18.34±21.46 .377 
% days vms mean(sd) 31.55±34.80 30.29±32.71 36.66±34.30 .321 
IDS mean(sd) 4.13±2.58 4.44±2.71 5.33±2.92 .003** 
STAI mean(sd) 14.63±3.66 15.29±4.82 15.84±4.64 .135 
Sleep Characteristics 
Duration mean(sd) 380.81±46.74 374.13±59.22 367.25±58.51 .197 
Wakefulness after sleep onset(sd) 52.30±27.86 51.06±30.05 54.79±34.28 .648 
Latency 17.41±13.76 22.72±24.05 23.05±21.38 .077 
PSQI 5.38±2.97 5.21±2.94 6.30±3.18 .015* 
AHI 7.67±7.25 7.33±9.17 9.13±10.31 .293 
% days sleep meds 31.50±45.15 16.08±35.71 30.42±45.27 .009** 
*p < .05. **p < .01. ***p < .001. 
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Table 4 
Demographic, health and sleep characteristics across low, moderate and high bedtime delay categories 
  Bedtime Delay 
 Low 
(n=105) 
Moderate 
(n=118) 
High 
(n=115) 
Sig 
Demographic Characteristics 
Age mean(sd) 52.30±2.14 51.97±2.03 52.06±1.90 .446 
Race 
   White N(%) 
   Black N(%) 
   Chinese N(%) 
 
60(57.14) 
21(20.00) 
24(22.86) 
 
 
60(50.85) 
41(34.75) 
17(14.41) 
 
41(35.65) 
59(51.30) 
15(13.04)  
 
<.001*** 
Marital Status 
   Married/living w partner N(%) 
Education 
   ≥ college degree N(%) 
 
74(70.48) 
 
80(67.80) 
 
65(56.52) 
 
.067 
 
68(64.76) 
 
59(50.00) 
 
47(40.87) 
 
.001** 
Employment 
   Unemployed or <20 hrs/wk N(%) 
 
25(23.81) 
 
17(14.41) 
 
26(22.61) 
 
.155 
Menopausal Status 
   Peri/early peri-menopausal N(%) 
 
69(65.71) 
 
74(62.71) 
 
68(59.13) 
 
.600 
Health Characteristics 
BMI mean(sd) 27.16±6.39 29.75±7.18 31.52±8.36 <.001*** 
HOMA-IR mean(sd) 1.40±0.76 1.71±0.99 2.03±1.77 .004** 
Current smoker N(%) 6(5.71) 13(11.02) 15(13.04) .179 
Caffeine consumption mean(sd) 1.65±1.31 1.56±1.37 1.51±1.42 .748 
Alcohol consumption mean(sd) 0.33±0.50 0.34±0.58 0.20±0.40 .079 
% days mod/vig exercise mean(sd) 22.63±24.47 21.85±24.95 18.15±22.14 .325 
% days vms mean(sd) 26.89±32.64 35.51±33.97 35.55±34.61 .095 
IDS mean(sd) 3.87±2.27 4.97±3.01 5.02±2.85 .003** 
STAI mean(sd) 14.84±4.02 15.95±5.07 14.98±4.07 .122 
Sleep Characteristics 
Duration mean(sd) 381.26±47.35 374.96±54.69 365.93±55.51 .120 
Wakefulness after sleep onset(sd) 49.71±28.42 52.26±28.93 55.92±34.69 .326 
Latency 17.80±15.16 22.00±24.09 23.48±20.58 .106 
PSQI 4.79±2.29 5.95±3.42 6.07±3.15 .003** 
AHI 7.36±7.51 7.23±6.30 9.49±12.07 .116 
% days sleep meds 21.93±40.50 27.51±42.76 27.30±44.38 .551 
*p < .05. **p < .01. ***p < .001. 
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Table 5 
Demographic, health and sleep characteristics across low, moderate and high social jetlag categories 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*p < .05. **p < .01. ***p < .001. 
                               Social Jetlag 
 Low 
(n=112) 
Moderate 
(n=114) 
High 
(n=112) 
Sig 
Demographic Characteristics 
Age mean(sd) 52.21±2.04 52.19±2.19 51.91±1.82 .472 
Race 
   White N(%) 
   Black N(%) 
   Chinese N(%) 
 
47(41.96) 
45(40.18) 
20(17.86) 
 
55(48.25) 
39(34.21) 
20(17.54) 
 
59(52.68) 
37(33.04) 
16(14.29) 
 
.590 
Marital Status 
   Married/living w partner N(%) 
 
63(56.25) 
 
83(72.81) 
 
73(65.18) 
 
.033* 
Education 
   ≥ college degree N(%) 
 
55(49.11) 
 
62(54.39) 
 
57(50.89) 
 
.767 
Employment 
   Unemployed or <20 hrs/wk N(%) 
 
32(28.57) 
 
19(16.67) 
 
17(15.18) 
 
.023* 
Menopausal Status 
   Peri/early peri-menopausal N(%) 
 
72(64.29) 
 
72(63.16) 
 
67(59.82)  
 
.899 
Health Characteristics 
BMI mean(sd) 30.04±7.68 29.37±8.32 29.24±6.64 .694 
HOMA-IR mean(sd) 1.58±0.84 1.80±1.57 1.80±1.35 .395 
Current smoker N(%) 12(10.71) 6(5.26) 16(14.29) .076 
Caffeine consumption mean(sd) 1.42±1.49 1.63±1.28 1.65±1.32 .389 
Alcohol consumption mean(sd) 0.24±0.42 0.31±0.60 0.32±0.47 .381 
% days mod/vig exercise mean(sd) 25.20±26.97 18.07±21.46 19.28±22.52 .057 
% days vms mean(sd) 40.10±37.06 27.76±31.98 30.76±31.54 .017* 
IDS mean(sd) 4.96±2.74 4.33±2.62 4.65±2.97 .228 
STAI mean(sd) 15.49±4.40 15.54±5.03 14.80±3.81 .383 
Sleep Characteristics 
Duration mean(sd) 372.49±62.02 374.36±54.75 374.71±49.68 .951 
Wakefulness after sleep onset(sd) 56.30±32.02 54.36±33.32 47.49±26.37 .081 
Latency 24.99±26.51 17.60±12.93 21.11±19.55 .026* 
PSQI 6.01±3.21 5.50±3.15 5.40±2.81 .286 
AHI 8.04±10.08 7.90±7.88 8.23±9.23 .964 
% days sleep meds 28.02±43.96 24.38±41.62 24.73±42.45 .780 
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Table 6  
Summary of regression analyses examining cross-sectional associations between sleep-timing 
variables and BMI (N=338) 
a
 Adjusted for race, menopausal status, exercise, depression and sleep duration; *p < .05. **p < .01. ***p < .001. 
 
 
 
  
 Unadjusted Model 1a 
 ΔR2 β ΔR2 β 
Average Bedtime .010 .099 .002 .046 
Variability in Bedtime  .036 .190*** .003 .055 
Social Jetlag .003 -.052 .004 -.067 
Bedtime Delay .067 .258*** .014 .128** 
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Table 7  
Summary of regression analyses examining cross-sectional associations between sleep-timing 
variables and HOMA-IR (N=335) 
a
 Adjusted for race, menopausal status, exercise, depression and sleep duration; 
b
Adjusted for race, menopausal 
status, exercise, depression, sleep duration and BMI;
 t
p<.1.*p<.05. **p<.01. ***p<.001. 
 
 
 
  
 Unadjusted Model 1a Model 2b 
   
 ΔR2 β ΔR2 β ΔR2 β 
Average Bedtime .006 .079 .000 -.002 .001 -.025 
Variability in Bedtime  .071 .266*** .023 .164** .015 .13** 
Social Jetlag .000 .021 .001 .027 .004 .064 
Bedtime Delay .067 .258*** .026 .171** .008 .098* 
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Table 8  
Summary of regression analyses examining prospective associations between sleep-timing 
variables and BMI (N=306) 
a
Adjusted for race, menopausal status, exercise, depression and sleep duration; 
b
further adjusted for BMI at Time 1; 
*p<.05. **p<.01. ***p<.001. 
 
 
 
 
 
 
 
 
 
  
 Unadjusted Model1a Model2b 
 ΔR2 β ΔR2 β ΔR2 β 
Average Bedtime .018 .136* .007 .085 .000 .014 
Variability in Bedtime  .022 .148** .001 .031 .000 .001 
Social Jetlag .001 -.025 .001 -.036 .001 .028 
Bedtime Delay .046 .213*** .007 .091 .001 .025 
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Table 9  
Summary of regression analyses examining prospective associations between sleep-timing 
variables and HOMA-IR (N=241) 
a
Adjusted for race, menopausal status, exercise, depression, sleep duration and BMI; 
b
further adjusted for HOMA-
IR at Time 1; *p<.05. **p<.01. ***p<.001. 
 
  
 Unadjusted Model1a Model2b 
 ΔR2 β ΔR2 β ΔR2 β 
Average Bedtime .001 -.025 .009 -.095 .008 -.090 
Variability in Bedtime  .003 .058 .000 -.023 .001 -.033 
Social Jetlag .002 .045 .001 .028 .000 .004 
Bedtime Delay .019 .139* .000 .005 .000 -.001 
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Table 10  
Sensitivity analysis examining cross-sectional associations between sleep-timing variables and 
HOMA-IR excluding Chinese women (N=279) 
a
 Adjusted for race, menopausal status, exercise, depression and sleep duration; 
b
Adjusted for race, menopausal 
status, exercise, depression, sleep duration and BMI;
 t
p<.1.*p<.05. **p<.01. ***p<.001. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 Unadjusted Model 1a Model 2b 
   
 ΔR2 β ΔR2 β ΔR2 β 
Average Bedtime .065 .254*** .025 .170** .007 .090t 
Variability in Bedtime  .000 .021 .001 .032 .005 .071 
Social Jetlag .007 .086 .000 .005 .000 -.022 
Bedtime Delay .072 .269*** .027 .181** .017 .143** 
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Figure 1 
Nocturnal Energy Expenditure and Light at Night 
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Figure 2 
Mean Sleep Timing Values among Caucasian, African American and Chinese Women 
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Figure 3 
Interaction between race and variability in bedtime predicting HOMA-IR 
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APPENDIX TABLES 
 
Table A1 
Correlation matrix among sleep timing variables 
 AB T1 BV T1 BD T1 SJ T1 
Avg Bedtime T1 -- .284*** .207*** .027 
Bedtime Var T1  -- .409*** .019 
Bedtime Delay T1   -- .195*** 
Social Jetlag T1    -- 
*p<.05. **p<.01. ***p<.001. 
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Table A2  
Cross-sectional regression results predicting BMI with average bedtime (N=338) 
*p<.05. **p<.01. ***p<.001. 
 
 
 
 
  
 B SE p 
Step 1    
Race    
African American 2.426 .837 .004** 
Chinese -6.177 1.016 <.001*** 
Menopausal Status 1.146 .731 .118 
Exercise -.042 .015 .006** 
Depression .536 .129 <.001*** 
Sleep Duration -.016 .007 .016* 
Step 2    
Average Bedtime .006 .006 .345 
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Table A3  
Cross-sectional regression results predicting BMI with variability in bedtime (N=338) 
*p<.05. **p<.01. ***p<.001. 
 
 
 
  
 B SE p 
Step 1    
Race    
African American 2.250 .866 .010** 
Chinese -6.104 1.009 <.000*** 
Menopausal Status 1.149 .731 .117 
Exercise -.043 .015 .004** 
Depression .526 .130 <.001*** 
Sleep Duration -.017 .007 .012* 
Step 2    
Variability in Bedtime .223 .205 .277 
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Table A4  
Cross-sectional regression results predicting BMI with bedtime delay (N=338) 
*p<.05. **p<.01. ***p<.001. 
 
 
 
 
 
 
  
 B SE p 
Step 1    
Race    
African American 1.989 .848 .020* 
Chinese -5.970 1.00 <.000*** 
Menopausal Status 1.040 .725 .153 
Exercise -.042 .015 .005** 
Depression .498 .129 <.001*** 
Sleep Duration -.017 .007 .153 
Step 2    
Bedtime Delay .017 .007 .010** 
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Table A5  
Cross-sectional regression results predicting BMI with social jetlag 
*p<.05. **p<.01. ***p<.001. 
 
 
 
 
 
 
 
 
 
 
  
 B SE p 
Step 1    
Race    
African American 2.412 .833 .004 
Chinese -6.157 1.009 <.000*** 
Menopausal Status 1.218 .732 .097 
Exercise -.045 .015 .003** 
Depression .544 .128 <.001*** 
Sleep Duration -.017 .007 .010** 
Step 2    
Social Jetlag -.012 .008 .159 
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Table A6  
Cross-sectional regression results predicting HOMA-IR with average bedtime (N=335) 
*p<.05. **p<.01. ***p<.001. 
 
 
 
 
  
 B SE p 
Step 1    
Race    
African American .091 .057 .110 
Chinese .242 .072 .001*** 
Menopausal Status .020 .049 .688 
Exercise -.001 .001 .466 
Depression .016 .009 .070 
Sleep Duration .000 .000 .438 
Step 2    
BMI .041 .004 <.000*** 
Step 3    
Average Bedtime .000 .000 .577 
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Table A7  
Cross-sectional regression results predicting HOMA-IR with variability in bedtime (N=335) 
*p<.05. **p<.01. ***p<.001. 
 
 
 
 
 
  
 B SE p 
Step 1    
Race    
African American .043 .058 .462 
Chinese .224 .070 .002** 
Menopausal Status .025 .049 .613 
Exercise -.001 .001 .444 
Depression .011 .009 .197 
Sleep Duration .000 .000 .446 
Step 2    
BMI .040 .004 <.000*** 
Step 3    
Variability in Bedtime  .038 .014 .005** 
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Table A8  
Cross-sectional regression results predicting HOMA-IR with bedtime delay (N=335) 
*p<.05. **p<.01. ***p<.001. 
 
 
 
 
 
  
 B SE p 
Step 1    
Race    
African American .061 .057 .285 
Chinese .235 .071 .001*** 
Menopausal Status .017 .049 .732 
Exercise -.001 .001 .482 
Depression .013 .009 .136 
Sleep Duration .000 .000 .395 
Step 2    
BMI .040 .004 <.001*** 
Step 3    
Bedtime Delay .001 .000 .038* 
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Table A9  
Cross-sectional regression results predicting HOMA-IR with social jetlag (N=335) 
*p<.05. **p<.01. ***p<.001. 
 
 
 
 
 
 
  
 B SE p 
Step 1    
Race    
African American .092 .056 .102 
Chinese .245 .071 .001*** 
Menopausal Status .015 .049 .767 
Exercise -.001 .001 .576 
Depression .016 .009 .072 
Sleep Duration .000 .000 .503 
Step 2    
BMI .041 .004 <.001*** 
Step 3    
Social Jetlag .001 .001 .152 
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Table A10  
Prospective regression results predicting BMI with average bedtime (N=306) 
*p<.05. **p<.01. ***p<.001. 
 
 
 
 
 
  
 B SE p 
Step 1    
Race    
African American -.657 .319 .041* 
Chinese -1.066 .383 .006** 
Menopausal Status -.026 .270 .924 
Exercise -.015 .006 .010** 
Depression .016 .048 .746 
Sleep Duration -.001 .002 .731 
Step 2    
BMI at Time 1 .942 .021 <.001*** 
Step 3    
Average Bedtime .002 .002 .453 
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Table A11  
Prospective regression results predicting BMI with variability in bedtime (N=306) 
*p<.05. **p<.01. ***p<.001. 
 
 
 
 
 
 
  
 B SE p 
Step 1    
Race    
African American -.632 .331 .057 
Chinese -1.028 .381 .007** 
Menopausal Status -.036 .271 .896 
Exercise -.015 .006 .009** 
Depression .019 .049 .698 
Sleep Duration -.001 .002 .679 
Step 2    
BMI at Time 1 .943 .021 <.001*** 
Step 3    
Variability in Bedtime .002 .074 .976 
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Table A12  
Prospective regression results predicting BMI with bedtime delay (N=306) 
*p<.05. **p<.01. ***p<.001. 
 
 
 
 
  
 B SE p 
Step 1    
Race    
African American -.722 .324 .027* 
Chinese -1.025 .379 .007** 
Menopausal Status -.054 .270 .842 
Exercise -.015 .006 .011* 
Depression .013 .048 .785 
Sleep Duration -.001 .002 .626 
Step 2    
BMI at Time 1 .941 .021 <.001*** 
Step 3    
Bedtime Delay .003 .003 .184 
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Table A13  
Prospective regression results predicting BMI with social jetlag (N=306) 
*p<.05. **p<.01. ***p<.001. 
 
 
 
 
 
 
 
  
 B SE p 
Step 1    
Race    
African American -.581 .318 .068 
Chinese -.969 .381 .011* 
Menopausal Status -.076 .270 .778 
Exercise -.014 .006 .014* 
Depression .021 .048 .666 
Sleep Duration -.001 .002 .749 
Step 2    
BMI at Time 1 .946 .021 <.001*** 
Step 3    
Social Jetlag .005 .003 .119 
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Table A14  
Prospective regression results predicting HOMA-IR with average bedtime (N=241) 
*p<.05. **p<.01. ***p<.001. 
 
 
 
  
 B SE p 
Step 1    
Race    
African American .158 .053 .003** 
Chinese .006 .062 .925 
Menopausal Status .087 .045 .054 
Exercise -.001 .001 .416 
Depression -.028 .008 .001*** 
Sleep Duration .000 .000 .285 
BMI .020 .004 <.001*** 
Step 2    
HOMA-IR at Time 1 .426 .080 <.001*** 
Step 3    
Average Bedtime -.001 .000 .088 
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Table A15  
Prospective regression results predicting HOMA-IR with variability in bedtime (N=241) 
*p<.05. **p<.01. ***p<.001. 
 
 
 
 
 
 
  
 B SE p 
Step 1    
Race    
African American .159 .055 .004** 
Chinese -.007 .062 .904 
Menopausal Status .088 .046 .054 
Exercise -.001 .001 .491 
Depression -.029 .008 <.001*** 
Sleep Duration .001 .000 .216 
BMI .019 .004 <.001*** 
Step 2    
HOMA-IR at Time 1 .431 .081 <.001*** 
Step 3    
Variability in Bedtime -.008 .013 .549 
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Table A16  
Prospective regression results predicting HOMA-IR with bedtime delay (N=241) 
*p<.05. **p<.01. ***p<.001. 
 
 
 
 
  
 B SE p 
Step 1    
Race    
African American .150 .054 .006** 
Chinese -.010 .062 .868 
Menopausal Status .092 .045 .044* 
Exercise -.001 .001 .485 
Depression -.029 .008 <.001*** 
Sleep Duration .000 .000 .226 
BMI .019 .004 <.001*** 
Step 2    
HOMA-IR at Time 1 .428 .081 <.001*** 
Step 3    
Bedtime Delay .000 .000 .989 
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Table A17  
Prospective regression results predicting HOMA-IR with social jetlag (N=241) 
*p<.05. **p<.01. ***p<.001. 
 
 
  
 B SE p 
Step 1    
Race    
African American .151 .054 .005** 
Chinese -.010 .062 .872 
Menopausal Status .091 .046 .046* 
Exercise -.001 .001 .492 
Depression -.029 .008 <.001*** 
Sleep Duration .000 .000 .224 
BMI .019 .004 <.001*** 
Step 2    
HOMA-IR at Time 1 .427 .081 <.001*** 
Step 3    
Social Jetlag .000 .000 .935 
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Table A18 
Body mass index and HOMA-IR Time 1 and Time 2 correlations 
 
 
 
 
 
*p<.05. **p<.01. ***p<.001. 
 
  
 Time 1 Time 2 R
2
 t-statistic p 
HOMA-IR 1.51 ± .93 1.49 ± 1.41 .429 .288 .773 
BMI 28.95 ± 7.22 29.40 ± 7.29 .950 -3.414 .001*** 
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Table A19 
Significant differences between participants included and excluded from primary analyses 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*p<.05. **p<.01. ***p<.001. 
 
  
 Included 
(n=338) 
Excluded 
(n=32) 
Statistic  
(Chi
2
 or t) 
Age 
 
Race 
 N(%) Caucasian 
 N(%) African American 
 N(%) Chinese 
52.10±2.02 
 
161(47.63) 
121(35.80) 
56(16.57) 
52.54±1.97 
 
12(37.50) 
17(53.13) 
3(9.37) 
1.159 
 
3.943 
 
 
Menopausal Status 
 N(%) Pre- or Early Peri- 
 N(%) Late Per- or Post 
 
 
 
211(62.43) 
127(37.57) 
 
 
17(53.13) 
15(46.87) 
 
 
1.069 
Employment 
 N(%) Unemployed or <20 hrs/week 
 N(%) Employed or ≥20 hrs/week 
 
 
68(20.12) 
270(79.88) 
 
12(37.50) 
20(62.50) 
 
5.212* 
Marital Status 
  N(%) Married or living as married 
  N(%) Single, widowed or divorced 
 
 
219(64.79) 
119(35.21) 
 
16(50.00) 
16(50.00) 
 
2.760 
BMI 29.55±7.57 35.64±8.65 3.846*** 
HOMA-IR 1.68±1.28 3.47±3.31 3.042** 
Exercise (% days ± SD) 20.84±23.89 11.28±16.75 -2.749** 
Alcohol (mean daily serving ± SD) 0.29±0.50 0.14±0.31 -2.285* 
Depression 4.65±2.78 6.16±3.98 2.073* 
Wakefulness after Sleep Onset 52.71±30.87 71.83±40.21 3.254*** 
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